The medical community has achieved a significant milestone with the approval of the first CRISPR gene editing therapy for Sickle Cell Disease. This groundbreaking development follows more than a decade after biochemist Jennifer Doudna co-invented CRISPR technology, which later won her the Nobel Prize in chemistry. Jennifer Doudna's lab, @doudna_lab, discussed the achievement with @WalterIsaacson. The Doudna institute, recognizing the economic challenges CRISPR faces in addressing very rare diseases, is collaborating with a medical conglomerate to expand the potential of this technology. They aim to tackle the high costs and time investments currently associated with gene editing treatments, as highlighted by Fyodor Urnov's comment on the impracticality of spending four years and $8 million every time a guide RNA is switched. The institute's ambitious plan is to 'cure hundreds of diseases' that have been overlooked in the wake of the CRISPR revolution, a vision supported by the medical conglomerate $DHR.
Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution https://t.co/aEozwycf4l via @statnews $DHR
Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution. One key challenge: “We cannot live in the world where switching a guide RNA sets us back four years and $8 million,” Fyodor Urnov says. https://t.co/VGdEQMQJZg via @statnews
Jennifer Doudna, @UrnovFyodor hatch plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution https://t.co/AgpVVBJgZW
The economics of CRISPR don't currently work for very rare diseases. The Doudna institute is teaming up with a medical conglomerate to try to change that. https://t.co/M2xCUNhwef
More than a decade ago, biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the first treatment based on CRISPR has been approved. @doudna_lab joins @WalterIsaacson to discuss. https://t.co/wfrBOVBxyp
Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy https://t.co/83zN8asPeh https://t.co/ToUQt7TaK6